Stocks-CMPS-COMPASS Pathways plc

CMPS COMPASS Pathways plc

8.00 -0.25 (-3.05%)
Forsinkede priser fra NASDAQ, i USD Markedet er åpent
Investere
Stocks-CMPS-COMPASS Pathways plc
CMPS COMPASS Pathways plc
Investere

Resultat

10.32% Forrige uke
Created with Highcharts 4.2.7 /Highstock 4.2.7
Markedsverdi
353.36M
Dagens område
7.85
-
8.26
52U-område
6.96
-
21.31
Volum (3M)
265.57K
Pris-inntjeningsforhold
-4.17
Inntekt
-

Siste nytt om COMPASS Pathways plc

Se alt
Compass Pathways Gets Good News On Psilocybin Patent JourneyCompass Pathways Gets Good News On Psilocybin Patent JourneyGreen Market Report2 dager sidenCOMPASS Pathways' key patents upheld by the US Patent and Trademark OfficeCOMPASS Pathways' key patents upheld by the US Patent and Trademark OfficeGreen Stock News2 dager sidenCOMPASS Pathways' Co-Founder Ekaterina Malievskaia to Step Down as Chief Innovation OfficerCOMPASS Pathways' Co-Founder Ekaterina Malievskaia to Step Down as Chief Innovation OfficerBenzinga8 dager siden
Diskusjoner om Topp
DeepNews
eToro
7 dager siden
$CMPS (COMPASS Pathways plc) Numinus' Clinical Site Joins Compass' Phase 3 Program On Psilocybin Therapy For TRD Numinus Wellness Inc.’s (OTCMKTS: NUMIF) wholly-owned contract research organization Cedar Clinical Research has commenced a new study on COMPASS Pathways’ (NASDAQ: CMPS) psilocybin... Vis flere Oversett
Numinus' Clinical Site Joins Compass' Phase 3 Program On Psilocybin Therapy For TRD
markets.businessinsider.com
Numinus Wellness Inc.’s (OTCMKTS: NUMIF) wholly-owned contract research organization Cedar Clinical Research has commenced a new study on COMPASS Pathways’ (NASDAQ: CMPS) psilocybin therapy for Treatment-Resistant Depression (TRD). 
Lik KommenterDel
DeepNews
eToro
9 dager siden
$CMPS (COMPASS Pathways plc) Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Jazz Pharmaceuticals (JAZZ) and COMPASS Pathways (CMPS) markets.businessinsider.com/news/stocks/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-jazz-pharmaceuticals-jazz-and-compass-pathways-cmps-1032358216 Oversett
Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Jazz Pharmaceuticals (JAZZ) and COMPASS Pathways (CMPS)
markets.businessinsider.com
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Vertex Pharmaceuticals (VRTX – Research Rep...
Lik KommenterDel
Jonathan Olsen
Sverige
13 dager siden
Redigert
🚀 Breaking News! 🚀 COMPASS Pathways (Nasdaq: CMPS) is making waves in the mental healthcare sector! 🧠💪 COMPASS Pathways has just announced the upcoming presentation of remarkable data at ASCO 2023. This data showcases the long-term improvement in depression among cancer patients who received a single... Vis flere Oversett
Lik KommenterDel
null
.
DeepNews
eToro
8 dager siden
$CMPS (COMPASS Pathways plc) COMPASS Pathways' Co-Founder Ekaterina Malievskaia to Step Down as Chief Innovation Officer COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation, today announced that Co-founder... Vis flere Oversett
Lik KommenterDel
DeepNews
eToro
23 dager siden
Analysts Offer Insights on Healthcare Companies: Zynerba Pharmaceuticals (ZYNE) and COMPASS Pathways (CMPS)
markets.businessinsider.com
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Zynerba Pharmaceuticals (ZYNE – Research Re...
Lik KommenterDel

Om COMPASS Pathways plc

COMPASS Pathways plc er et helseforetak, som opererer i Storbritannia og USA. De jobber med bevisbasert innovasjon innen mental helse. Selskapet var tidligere kjent som COMPASS Rx Limited, og fikk sitt nye navn i 2020. De har hovedkontor i Cheshire, Storbritannia. Aksjen er notert på NASDAQ, og har aksjesymbolet CMPS. Legg til COMPASS Pathways-aksjen på eToro, og få siste nytt om prisbevegelsene.
-
Ansatte
London, Cheshire, US
Hovedkontor
2020
Grunnlagt
Kabir Kumar Nath, MBA
CEO
Show More
Medisinsk teknologiNASDAQ

Kommende inntekter

3
AUG
RAPPORTER
COMPASS Pathways plc Q2 2023 det forventes at inntektsrapporten publiseres før markedet åpner

Folk kjøpte også